4Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients [J ]. Diabetes Care,2007,30(5) : 1212-1218.
5Schindhelm RK, Diamant M, Bakker SJ, et al. Liver alanine aminotransferase,insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes meltitus [J]. Eur J Clin Invest,2005,35(6) :369-374.
6Targher G, Bertolini L, Poli F, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients[J]. Diabetes, 2005,54 (2) : 3541-3546.
7Sanyal AJ, American Gastroenterological Association. AGA technical review no nonalcoholic fatty liver disease ~J.~. Gastroenterology, 2002,123 (5) : 1705- 1725.
8Oliveira CP, da Costa Gayotto LC, Tatai C, et al. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-de{icient diet[J].J Cell Mol Med, 2002,6(3) :399-406.
9Choi S, Diehl AM. Role of inflammation in nonalcoholic steatohepatitis[J].Curr ()pin Gastroenterol, 2005, 21(6)~ 702 707.
